You are here: All Products  > Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation

Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products